• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra.golins.com

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Publications

Publications

Featured publications

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

November 2, 2023 | The New England Journal of Medicine
Mohit Mathur, et. al.

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Mohit Mathur, Jonathan Barratt, Bobby Chacko, Tak Mao Chan, Laura Kooienga, Kook-Hwan Oh, Manisha Sahay, Yusuke Suzuki, Muh Geot Wong, Jill Yarbrough, Jing Xia, Brian J G Pereira

>READ

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

April 5, 2023 | Frontiers in Molecular Biosciences
Steven Pregizer, et. al.

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Steven Pregizer, Thom Vreven, Mohit Mathur, Luke Robinson

>READ

Quantifying the nativeness of antibody sequences using long short-term memory networks

December 31, 2019 | Protein Engineering, Design, and Selection
Andrew M Wollacott, et. al.

Quantifying the nativeness of antibody sequences using long short-term memory networks

Andrew M Wollacott, Chonghua Xue, Qiuyuan Qin, June Hua, Tanggis Bohnuud, Karthik Viswanathan, Vijaya B Kolachalama

>READ

State-of-Art Therapeutics in IgA Nephropathy

August 30, 2024 | Indian Journal of Nephrology
Mohit Mathur et al.

State-of-Art Therapeutics in IgA Nephropathy

Mohit Mathur, Manisha Sahay, Brian J.G. Pereira, Dana V. Rizk

>READ

Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome

August 5, 2024 | Kidney360
John J. Sim et al.

Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome

John J. Sim, William E. Smoyer, Asher D. Schachter

>READ

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group

June 3, 2024 | Clinical Journal of the American Society of Nephrology
Carla Nester, et al.

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group

Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S. Bomback, Fernando Caravaca-Fontán, Terence H. Cook, David L. Feldman, Veronique Fremeaux-Bacchi, Daniel P. Gale, Ann Gooch, Sally Johnson, Christoph Licht, Mohit Mathur, Matthew C. Pickering, Manuel Praga, Giuseppe Remuzzi, Viknesh Selvarajah, Richard J. Smith, Hossein Tabriziani, Nicole van de Kar, Yaqin Wang, Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun, Howard Trachtman, Aliza Thompson

>READ

A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models

March 1, 2024 | The Journal of Clinical Investigation
Orhan Efe et al.

A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models

Orhan Efe, Rodrigo B. Gassen, Leela Morena, Yoshikazu Ganchiku, Ayman Al Jurdi, Isadora T. Lape, Predo Ventura-Aguiar, Christian LeGuern, Joren C. Madsen, Zachary Shriver, Gregory J. Babcock, Thiago J. Borges, Leonardo V. Ri

>READ

A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence

November 4, 2023 | Journal of Clinical Medicine
Mohit Mathur, et. al.

A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence

Mohit Mathur, Tak Mao Chan, Kook-Hwan Oh, Laura Kooienga, Min Zhuo, Cibele S. Pinto, Bobby Chacko

>READ

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

November 2, 2023 | The New England Journal of Medicine
Mohit Mathur, et. al.

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Mohit Mathur, Jonathan Barratt, Bobby Chacko, Tak Mao Chan, Laura Kooienga, Kook-Hwan Oh, Manisha Sahay, Yusuke Suzuki, Muh Geot Wong, Jill Yarbrough, Jing Xia, Brian J G Pereira

>READ

Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections

September 19, 2023 | PLOS Pathogens
Kenneth Johnson et al.

Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections

Kenneth Johnson, James C. Delaney, Thomas Guillard, Fany Reffuveille, Jennifer Varin-Simon, Kai Li, Andrew Wollacott, Eric Frapy, Surin Mong, Hamid Tissire, Karthik Viswanathan, Faycal Touti, Gregory J. Babcock, Zachary Shriver, Bradley L. Pentelute, Obadiah Plante, David Skurnik

>READ

Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants

August 11, 2023 | Clinical Development in Drug Pharmacology
Xiaoyan Zhang, et. al.

Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants

Xiaoyan Zhang, Yanlin Wang, Jill Yarbrough, Mohit Mathur, Lee Andrews, Brian J G Pereira, Susan E Sloan, Asher D Schachter

>READ

Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review

August 4, 2023 | Kidney360
Krzysztof Kiryluk et al.

Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review

Krzysztof Kiryluk, Daniel E. Freedberg, Jai Radhakrishnan, Leslie Segall, Judith S. Jacobson, Mohit Mathur, Sumit Mohan, Alfred I. Neugut

>READ

The incidence and prevalence of IgA nephropathy in Europe

May 8, 2023 | Nephrology Dialysis Transplantation
Cynthia J. Willey et al.

The incidence and prevalence of IgA nephropathy in Europe

Cynthia J. Willey, Rosanna Coppo, Franz Schaefer, Malgorzata Mizerska-Wasiak, Mohit Mathur, Michaela J. Schultz

>READ
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »

© 2025 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design

We use cookies on our website to see how you interact with it. By accepting, you agree to our use of such cookies. Privacy PolicyOk